Ovarian hormone modulates 5-hydroxytryptamine 3 receptors mRNA expression in rat colon with restraint stress-induced bowel dysfunction

World Journal of Gastroenterology

Volumn 10, Issue 18, 2004, Pages 2723-2726

  Li, Tian Jin ^a   Yu, Bao Ping ^a   Dong, Wei Guo ^a   Luo, He Sheng ^a   Xu, Long ^a   Li, Mu Qi ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL BENZOATE PLUS PROGESTERONE; ESTROGEN; MESSENGER RNA; PROGESTERONE; SEROTONIN 3 RECEPTOR; SEX HORMONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEFECATION; DISEASE ASSOCIATION; ESTROGEN BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; HORMONAL REGULATION; HORMONE DETERMINATION; HORMONE INHIBITION; IMMOBILIZATION STRESS; IRRITABLE COLON; NONHUMAN; OVARIECTOMY; PATHOPHYSIOLOGY; PROGESTERONE BLOOD LEVEL; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; RANDOMIZATION; RAT; RAT STRAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 4544340266     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i18.2723     Document Type: Article

References (32)

1. Heitkemper M, Jarrett M. Irritable bowel syndrome: causes and treatment. Gastroenterol Nurs 2000; 23: 256-263
2. Leahy A, Epstein O. Non-pharmacological treatments in the irritable bowel syndrome. World J Gastroenterol 2001; 7: 313-316
3. Olden KW. Diagnosis of irritable bowel syndrome. Gastroenterology 2002; 122: 1701-1714
4. Foxx-Orenstein AE, Clarida JC. Irritable bowel syndrome in women: the physician-patient relationship evolving. J Am Osteopath Assoc 2001; 101(12 Suppl Pt 2): S12-16
5. Camilleri M. Management of the irritable bowel syndrome. Gastroenterology 2001; 120: 652-668
6. Saito YA, Schoenfeld P, Locke GR 3rd. The epidemiology of irritable bowel syndrome in North America: a systematic review. Am J Gastroenterol 2002; 97: 1910-1915
7. Triadafilopoulos G, Finlayson M, Grellet C. Bowel dysfunction in postmenopausal women. Women Health 1998; 27: 55-66
8. Houghton LA, Lea R, Jackson N, Whorwell PJ. The menstrual cycle affects rectal sensitivity in patients with irritable bowel syndrome but not healthy volunteers. Gut 2002; 50: 471-474
9. Ryan JP, Bhojwani A. Colonic transit in rats: effect of ovariectomy, sex steroid hormones, and pregnancy. Am J Physiol 1986; 251(1 Pt 1): G46-50
10. Hunt RH, Tougas G. Evolving concepts in functional gastrointestinal disorders: promising directions for novel pharmaceutical treatments. Best Pract Res Clin Gastroenterol 2002; 16: 869-883
11. Viramontes BE, Camilleri M, McKinzie S, Pardi DS, Burton D, Thomforde GM. Gender-related differences in slowing colonic transit by a 5-HT3 antagonist in subjects with diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol 2001; 96: 2671-2676
12. Li J, Liu X, Xie P, Gu Q, Li J, Zhang Y, Tang Z. The regulation of calcium in the movement of colonic smooth muscle in wrap restraint stress rats. Zhonghua Neike Zazhi 2000; 39: 588-591
13. Miyata K, Kamato T, Nishida A, Ito H, Yuki H, Yamano M, Tsutsumi R, Katsuyama Y, Honda K. Role of the serotonin3 receptor in stress-induced defecation. J Pharmacol Exp Ther 1992; 261: 297-303
14. Bond EF, Heitkemper MM, Bailey SL. Estrogen suppresses gastric motility response to thyrotropin-releasing hormone and stress in awake rats. Res Nurs Health 1998; 21: 221-228
15. Oz M, Zhang L, Spivak CE. Direct noncompetitive inhibition of 5-HT(3) receptor-mediated responses by forskolin and steroids. Arch Biochem Biophys 2002; 404: 293-301
16. Williams CL, Villar RG, Peterson JM, Burks TF. Stress-induced changes in intestinal transit in the rat: a model for irritable bowel syndrome. Gastroenterology 1988; 94: 611-621
17. Isenberg KE, Ukhun IA, Holstad SG, Jafri S, Uchida U, Zorumski CF, Yang J. Partial cDNA cloning and NGF regulation of a rat 5-HT3 receptor subunit. Neuroreport 1993; 5: 121-124
18. Dou DB, Huang YW, Wang SP, Cai G, Lin J. Influence of Zhishi Xiaopi pill on gene expression of CCK and CCK-A receptor in upper-alimentary tract of rats. Shijie Huaren Xiaohua Zazhi 2002; 10: 927-930
19. Camilleri M. Pathophysiology in irritable bowel syndrome. Drug News Perspect 2001; 14: 268-278
20. Heitkemper MM, Jarrett M. Pattern of gastrointestinal and somatic symptoms across the menstrual cycle. Gastroenterology 1992; 102: 505-513
21. Heitkemper MM, Jarrett M, Cain KC, Shaver J, Walker E, Lewis L. Daily gastrointestinal symptoms in women with and without a diagnosis of IBS. Dig Dis Sci 1995; 40: 1511-1519
22. Wald A, Van Thiel DH, Hoechstetter L, Gavaler JS, Egler KM, Verm R, Scott L, Lester R. Gastrointestinal transit: the effect of the menstrual cycle. Gastroenterology 1981; 80: 1497-1500
23. Bond EF, Heitkemper MM, Perigo R. Gastric emptying and gastric-intestinal transit in rats with varying ovarian hormone status. Nurs Res 1996; 45: 218-224
24. Perez Gutthann S, Garcia Rodriguez LA, Castellsague J, Duque Oliart A. Hormone replacement therapy and risk of venous thromboembolism: population based case-control study. BMJ 1997; 314: 796-800
25. Hutson WR, Roehrkasse RL, Wald A. Influence of gender and menopause on gastric emptying and motility. Gastroenterology 1989; 96: 11-17
26. Ruigomez A, Garcia Rodriguez LA, Johansson S, Wallander MA. Is hormone replacement therapy associated with an increased risk of irritable bowel syndrome? Maturitas 2003; 44: 133-140
27. Muraoka M, Mine K, Kubo C. A study of intestinal dysfunction induced by restraint stress in rats. Scand J Gastroenterol 1998; 33: 806-810
28. Glatzle J, Sternini C, Robin C, Zittel TT, Wong H, Reeve JR Jr, Raybould HE. Expression of 5-HT3 receptors in the rat gastrointestinal tract. Gastroenterology 2002; 123: 217-226
29. Zhai J, Gershon MD, Walsh JH, Wong HC, Kirchgessner AL. Inward currents in neurons from newborn guinea pig intestine: mediation by 5-hydroxytryptamine type 3 receptors. J Pharmacol Exp Ther 1999; 291: 374-382
30. Zhou X, Galligan JJ. Synaptic activation and properties of 5-hydroxytryptamine (3) receptors in myenteric neurons of guinea pig intestine. J Pharmacol Exp Ther 1999; 290: 803-810
31. Gutierrez B, Arranz MJ, Huezo-Diaz P, Dempster D, Matthiasson P, Travis M, Munro J, Osborne S, Kerwin RW. Novel mutations in 5-HT3A and 5-HT3B receptor genes not associated with clozapine response. Schizophr Res 2002; 58: 93-97
32. Camilleri M, Mayer EA, Drossman DA, Heath A, Dukes GE, McSorley D, Kong S, Mangel AW, Northcutt AR. Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist. Aliment Pharmacol Ther 1999; 13: 1149-1159